TECX FY 2024 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$58M

Net Income

-$58M

EPS (Diluted)

$-3.93

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$153M

Total Liabilities

$12M

Stockholders' Equity

$141M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$58M	-$45M	-29.9%
Net Income	-$58M	-$43M	-35.4%